Back to Search
DIPTI MIRCHANDANI, MD
MD
Pediatrics Physician
NPI: 1497041081Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
25MA11913400(NJ)
Research & Publications (9)
Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.
PMID 17301073·Ann Oncol·2007
8-other
Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
PMID 16505423·J Clin Oncol·2006
3-trial
Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer.
PMID 16115933·Clin Cancer Res·2005
3-trial
Case 1. Metastatic breast cancer presenting with panhypopituitarism.
PMID 15570089·J Clin Oncol·2004
5-case
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
PMID 15457856·J Reprod Med·2004
5-case
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
PMID 12679737·Anticancer Drugs·2003
3-trial
Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
PMID 11562395·J Natl Cancer Inst·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 26508 74th Ave Apt F1
Glen Oaks, NY 11004 - Phone
- (732) 672-9868
Quick Facts
- NPI
- 1497041081
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 9
Are you this provider?
Claim Your Profile